In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


KCI Medical Services

Division of 3M Co.

Latest From KCI Medical Services

KCI's Prevena Becomes First FDA-Cleared Negative Pressure Wound-Closure Device

The US FDA granted KCI's de novo request for the Prevena incision management system, making it the first negative pressure device cleared for reducing superficial surgical site infections in patients at high risk.

Approvals Wound Management

PolarityTE Launches Two Trials Of SkinTE Chronic Wound Therapy

Patient enrollment has begun in trials of SkinTE human cellular and tissue skin-repair product for diabetic foot ulcers and venous leg ulcers, the Salt Lake City company announced April 1.

Clinical Trials Commercial

KCI Awarded $645M In Stolen Device Case

An Ohio federal judge recently awarded $645m to Acelity subsidiary KCI Inc. The company sued Healthcare Essentials Inc. for allegedly stealing wound-therapy units for resale.

Legal Issues Commercial

Exec Chat: KCI CEO Andrew Eckert Foresees Big Year For Wound-Care Company

Since selling its LifeCell aesthetic and surgical products business to Allergan in early 2017, Acelity has refocused its commercial efforts, and its name, on the KCI wound-care business, with significant investments in medical education, clinical studies and R&D in that sector, as well as the recent acquisition of UK-based Crawford Healthcare.

Exec Chat Innovation
See All

Company Information